Tension and Trauma Releasing Exercises on Hypertensive Patients

Effect of Tension and Trauma Releasing Exercises on Quality of Life and Sleep in Patients With Hypertension

The aim of this study is to investigate the effect of Tension and Trauma Releasing Exercises (TRE) on the quality of life and sleep in hypertensive patients. Participants will perform a series of supervised TRE sessions, and their sleep quality, and quality of life will be assessed before and after the intervention to determine any potential improvements related to the exercise.

Study Overview

• Status: Not yet recruiting
• Conditions: Hypertension (HTN)
• Intervention / Treatment: Behavioral: Tension and trauma releasing exercises

Detailed Description

Forty females have had essential hypertension for at least five years. They will be recruited from the outpatient clinic at physical therapy, Cairo university.

The patients of this study will be randomly assigned into 2 equal groups (n=40):

Study Group A: (20 patients) Will receive Tension and Trauma Releasing Exercises in addition to medical treatment programme.

Control Group B: (20 patients) will receive only the Medical treatment programme.

The program of treatment for the study group will be applied 30 minutes per session , with a maximum of 15 minutes of neurogenic tremors, 3 times per week for 8 consecutive weeks.

• Study Type: Interventional
• Enrollment (Estimated): 40
• Phase: Not Applicable

Contacts and Locations

• Study Contact: Name: Youmna Gamal Elsayed, B.Sc. in Physical Therapy; Phone Number: +201223348743 +201273150655; Email: yomnagamal27@gmail.com

Study Locations

• Egypt
  • Giza, Egypt
    • faculty of physical therapy ,Cairo University
    • Contact: Youmna Gamal Elsayed, BSc. in Physical Therapy; Phone Number: +201273150655; Email: yomnagamal27@gmail.com

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

1. Participants will be between 50 and 65 years of age.
2. The BMI of patients will range between 30 and 34.9.
3. Patients included in the study were diagnosed with essential hypertension for at least five years.
4. The patients will be in stage 1 hypertension under medical control, characterized by systolic blood pressure ranging from 140 to 159 mmHg and diastolic blood pressure ranging from 90 to 99 mmHg.

Exclusion Criteria:

1. Patients suffering from any unstable cardiovascular condition, such as uncontrolled arrhythmias or recent myocardial infarction.
2. Patients are diagnosed with secondary hypertension.
3. Patients with cognitive or physical impairments that prevent them from following instructions.

e) Patients who are taking beta-blockers and alpha-blockers because these medications may affect heart rate.

f) Individuals with endocrine disorders or any condition known to influence hormonal levels.

g) Patients are smokers. h) Malignant hypertension.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Treatment
• Allocation: Randomized
• Interventional Model: Parallel Assignment
• Masking: None (Open Label)

Number of Arms

2

Arms and Interventions

Participant Group / Arm	Intervention / Treatment
Experimental: "TRE Exercise Group"; Participants in this group will perform supervised Tension and Trauma Releasing Exercise (TRE) sessions in addition to their usual medical treatment for hypertension. The TRE sessions will be conducted three times per week for eight weeks, and each session will last approximately 30 minutes. The exercises aim to promote relaxation, reduce tension, and improve sleep quality, and quality of life.	Behavioral: Tension and trauma releasing exercises; Tension and trauma releasing exercises will be conducted for study group only as follows: The exercises start by slightly fatiguing specific muscle groups to encourage this involuntary shaking, which is considered healthy and calming. The first exercise: Feet roll gently outward while shifting weight side to side, helping release ankle tension. The second exercise: One foot steps back while the front heel lifts until the calf feels lightly tired, triggering a small shake. The third exercise: A small lunge-like position engages the thighs and hips, leading to natural muscle release. The fourth exercise: A soft bend at the hips with relaxed arms and deep breathing stretches the back and encourages loosening. The fifth exercise: With feet wide and hands on the lower back, the hips push forward slightly while breathing deeply and turning gently side to side. The sixth exercise: The body slides into a seated position against a wall to lightly fatigue the
No Intervention: "Control Group"; Participants in this group will continue their usual medical treatment for hypertension without any additional exercise intervention. They will receive the same assessments for sleep quality, and quality of life as the experimental group.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Quality of life ,assessed by SF12	Change in SF-12 physical and mental component summary scores from baseline to 8 weeks.	Baseline and after 8 weeks of intervention
Sleep quality, assessed by the Pittsburgh Sleep Quality Index (PSQI).	Change in global PSQI score from baseline to 8 weeks. PSQI will be administered to assess sleep quality .	Baseline and 8 weeks after the start of the intervention

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Blood pressure - Systolic and Diastolic (mmHg) ,assessed by mercury sphygmomanometer	Mean change in systolic and diastolic blood pressure. Measurements will be taken using a mercury sphygmomanometer after a 5-minute rest period, and the average of two consecutive readings will be recorded.	Baseline and 8 weeks after the start of the intervention
Heart rate ,assessed by pulse oximeter	change in resting heart rate measured by pulse oximeter	Baseline and 8 weeks after the start of the intervention
Depression and anxiety ,assessed by Hospital Anxiety and Depression Scale (HADS)	Change in subscale (anxiety and depression) scores from baseline to 8 weeks.	Baseline and 8 weeks after the start of the intervention
Rate Pressure Product measurement	Heart rate * systolic blood pressure	Baseline and 8 weeks after the start of the intervention

Collaborators and Investigators

• Sponsor: Cairo University
• Investigators: Study Chair: El-Sayed Essam Felaya, Assistant professor, Cairo University; Study Chair: Salma Elsayed Elsheikh, Lecturer of physical therapy, Cairo University; Study Chair: Mahmoud Mohamed Ghanema, Lecturer of Internal Medicine, Cairo University

Study record dates

Study Major Dates

• Study Start (Estimated): November 18, 2025
• Primary Completion (Estimated): March 4, 2026
• Study Completion (Estimated): June 4, 2026

Study Registration Dates

• First Submitted: November 17, 2025
• First Submitted That Met QC Criteria: November 17, 2025
• First Posted (Actual): November 21, 2025

Study Record Updates

• Last Update Posted (Actual): November 21, 2025
• Last Update Submitted That Met QC Criteria: November 17, 2025
• Last Verified: November 1, 2025

More Information

Terms related to this study

• Keywords: Tension and trauma releasing exercises
• Additional Relevant MeSH Terms: Vascular Diseases; Cardiovascular Diseases; Hypertension
• Other Study ID Numbers: 111995

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No